Erythrocyte Transfusion
17
0
0
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
11.8%
2 terminated out of 17 trials
88.2%
+1.7% vs benchmark
24%
4 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (17)
Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations
Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants
Blood Salvage From Liver Donors: a Feasibility Pilot Study
Machine Learning Versus Traditional Scores in Predicting Erythrocyte Need
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
Cerebral Haemodynamic Changes by Red Blood Cell Transfusion in Neonates
Insufficient Cellular Oxygen in ICU Patients With Anaemia
Rejuvenated RBC and VO2 Max in Healthy Subjects
European Transfusion Practice and Outcome Study
The Long-term Clinical Outcomes and Patterns of Transfusion in PCI Patients: Retrospective Cohort Study
Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion
Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Impact of Blood Storage Duration on Physiologic Measures
Mechanism and Repository Study for the Red Cell Storage Duration Study
Red Cell Storage Duration Study
Red Blood Cells (RBC) Transfusion Related to Central Venous O2 Saturation (ScvO2) Measurement
Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery